Serge Goldner has founded a new company that will adapt therapies from the human health care market to the
Goldner is the former co-founder and CFO of Immune Pharma and a managing partner at Cukierman & Co.
Board members include investment experts Patrick Scherrer , a former CEO of Widmann Associates .
The animal health industry is a growing industry that represented a $22 billion market in 2011 of medicines and vaccines.
An advantage of animal health products is that development is generally faster and less expensive as R&D is more predictable.
Aratana Therapeutics which raised nearly $40 million in a recent IPO is an example of a success story in this field. Aratana is based on three compounds being developed for use in six animal health products.
A team of experts headed by Dr. Thierry Bardon, former VP of R&D at Ceva Sante Animale is currently picking out a list of in-licensing targets for Gour Medical.